Effect of antibodies to glutamate on retention of conditioned passive avoidance response in rats with ischemic injury of the prefrontal cortex

Bulletin of Experimental Biology and Medicine

Volumn 149, Issue 3, 2010, Pages 289-292

  Romanova, G A ^a   Shakova, F M ^a   Gorbatov, V Yu ^a   Kvashennikova, Yu N ^a   Davydova, T V ^a  

^a INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

Author keywords

antibodies to glutamate; learning; memory; photothrombosis; prefrontal cortex

Indexed keywords

GLUTAMIC ACID; GLUTAMIC ACID ANTIBODY; IMMUNOGLOBULIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONDITIONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; PASSIVE AVOIDANCE; PREFRONTAL CORTEX; RAT;

ANIMALS; ANTIBODIES; AVOIDANCE LEARNING; BRAIN ISCHEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTAMIC ACID; MALE; PHOTOCHEMISTRY; PREFRONTAL CORTEX; RATS; ROSE BENGAL; STATISTICS, NONPARAMETRIC;

RATTUS;

EID: 77956192158     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-010-0929-9     Document Type: Article

References (11)

1. J. Buresh, O. Bureshova, and J. P. Houston, Methods and Main Experiments for Studies of the Brain and Behavior [in Russian], Moscow (1991).
2. E. I. Gusev and V. I. Skvortsova, Cerebral Ischemia [in Russian], Moscow (2001).
3. TV Davydova NI Voskresenskaya VG Fomina, et al. 2007 Byull. Eksp. Biol. Med. 143 2 140 141 10.1007/s10517-007-0044-8
4. TV Davydova NI Voskresenskaya VG Fomina, et al. 2006 Ibid. 142 12 624 626
5. V. A. Evseev, Antibodies to Neurotransmitters in the Mechanisms of Neuroimmunopathology [in Russian], Moscow (2007).
6. GA Romanova IV Barskov RU Ostrovskaya, et al. 1998 Patol. Fiziol. Eksper. Ter. 2 8 10
7. G. A. Romanova, Dysregulation Pathology, Ed. G. N. Kryzhanovskii [in Russian], Moscow (2002), pp. 605-615.
8. The Rat Brain in Stereotaxic Coordinates. 3rd Edition, G. Paxinos and C. Watson, San Diego (1997).
9. P Seguela M Geffard R Buijs M Le Moal 1984 Proc. Natl. Acad. Sci. USA 81 12 3888 3892 10.1073/pnas.81.12.3888 1:CAS:528:DyaL2cXksFejsLg%3D 6587397
10. S Talegaonkar PR Mishra 2004 Indian J. Pharmacol. 36 140 147 1:CAS:528:DC%2BD2cXls1SgtLc%3D
11. BD Watson WD Dietrich R Busto, et al. 1985 Ann. Neurol. 17 5 497 504 10.1002/ana.410170513 1:STN:280:DyaL2M3itl2ntQ%3D%3D 4004172